Literature DB >> 27173833

The importance of quantitative measurement methods for uveitis: laser flare photometry endorsed in Europe while neglected in Japan where the technology measuring quantitatively intraocular inflammation was developed.

Carl P Herbort1,2, Ilknur Tugal-Tutkun3.   

Abstract

Laser flare photometry (LFP) is an objective and quantitative method to measure intraocular inflammation. The LFP technology was developed in Japan and has been commercially available since 1990. The aim of this work was to review the application of LFP in uveitis practice in Europe compared to Japan where the technology was born. We reviewed PubMed articles published on LFP and uveitis. Although LFP has been largely integrated in routine uveitis practice in Europe, it has been comparatively neglected in Japan and still has not received FDA approval in the USA. As LFP is the only method that provides a precise measure of intraocular inflammation, it should be used as a gold standard in uveitis centres worldwide.

Entities:  

Keywords:  Intraocular inflammation; Laser flare photometry; Uveitis

Mesh:

Year:  2016        PMID: 27173833     DOI: 10.1007/s10792-016-0253-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  21 in total

1.  Correlations between laser flare measurements and anterior chamber protein concentrations.

Authors:  S M Shah; D J Spalton; J C Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-09       Impact factor: 4.799

2.  Measurement of aqueous cells and flare in normal eyes.

Authors:  S M Shah; D J Spalton; S E Smith
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

3.  Editorial: Laser flare (cell) photometry: 20 years already.

Authors:  Carl P Herbort; Ilknur Tugal-Tutkun
Journal:  Int Ophthalmol       Date:  2010-07-01       Impact factor: 2.031

Review 4.  Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-05-09       Impact factor: 2.031

5.  New quantitative method to determine protein concentration and cell number in aqueous in vivo.

Authors:  M Sawa; Y Tsurimaki; T Tsuru; H Shimizu
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

6.  [Reproducibility of in vivo determination of protein and particle concentration with the laser flare cell photometer].

Authors:  M L Rödinger; V Hessemer; K Schmitt; B Schickel
Journal:  Ophthalmologe       Date:  1993-12       Impact factor: 1.059

7.  Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation.

Authors:  A el-Maghraby; A Marzouki; T M Matheen; J Souchek; M Van der Karr
Journal:  Arch Ophthalmol       Date:  1992-07

8.  Comparison between Outcomes of Vitrectomy in Granulomatous and Nongranulomatous Uveitis.

Authors:  Kei Takayama; Atushi Tanaka; Sho Ishikawa; Manabu Mochizuki; Masaru Takeuchi
Journal:  Ophthalmologica       Date:  2015-11-05       Impact factor: 3.250

9.  Evaluation of Intraocular Inflammation with Laser Flare Photometry in Behçet Uveitis.

Authors:  Fatime Nilufer Yalcindag; Pinar Bingol Kiziltunc; Esra Savku
Journal:  Ocul Immunol Inflamm       Date:  2016-01-30       Impact factor: 3.070

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  2 in total

1.  A case of severe flare reaction observed in HLA B27 associated acute anterior uveitis.

Authors:  Jae-Ik Kim; Choul Yong Park
Journal:  BMC Ophthalmol       Date:  2020-05-24       Impact factor: 2.209

2.  Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis.

Authors:  Sooyeon Choe; Jang Won Heo; Baek Lok Oh
Journal:  Korean J Ophthalmol       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.